Skip to content

Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section

Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section; a Randomized, Double Blinded, Placebo Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02194192
Enrollment
168
Registered
2014-07-18
Start date
2014-07-31
Completion date
2015-03-31
Last updated
2015-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia; Adverse Effect, Spinal and Epidural

Keywords

prevention of hypotension, spinal anesthesia, cesarean section, ephedrine, ondansetron

Brief summary

Maternal hypotension after spinal anesthesia in parturients undergoing cesarean section is a very common problem leading to several complications to both patients and their babies. It can cause maternal discomfort, lightheadedness, nausea and vomiting. The most important complication is the decreasing blood flow to babies; which may lead to fetal acidosis. Many interventions has been studied in order to prevent hypotension after spinal anesthesia in cesarean section e.g., fluid loading: colloid vs crystalloid, medications: ephedrine, phenylephrine, and metaraminol, etc. The recent study showed ondansetron (the antiemetic drug) can be effectively used to prevent hypotension after spinal anesthesia in normal patients or parturients. The action of ondansetron is believed to inhibit Bezold-Jarish reflex. This aim of this study is to compare the efficacy of ephedrine and ondansetron in the prevention of maternal hypotension after spinal anesthesia in cesarean section.

Interventions

DRUGPlacebo

Normal saline 10 ml

DRUGOndansetron

Ondasetron 8 mg IV after spinal anesthesia

DRUGEphedrine

Ephedrine 10 mg IV after spinal anesthesia

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \> 18 years * Elective cesarean section * Patient accept spinal anesthesia * ASA classification I-II * Term, Singleton pregnancy * Understand all process in this study

Exclusion criteria

* DM any type that not the gestational DM * Hypertensive disorder * BMI\>40 * Complicated pregnancy such as placenta previa, preeclampsia * Allergic to study drugs * Long QT syndrome * Contraindication to spinal anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Comparing efficacy of ondansetron to ephedrine in the prevention of hypotension.After spinal block to until baby deliveredOndansetron or ephedrine will be given immediately after spinal anesthesia, then record blood pressure and heart rate one-minutely until delivery.

Secondary

MeasureTime frame
Maternal symptom: Nausea and vomiting after spinal anesthesiaAfter spinal anesthesia until baby delivered

Other

MeasureTime frame
Apgar scoreone minute and five minute after delivery

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026